Artur L.Badra

Of Counsel

(T) + 55.11.3018.3920

Connect:

Share

Artur Badra has extensive experience coordinating the corporate legal strategy for global clients doing business in Latin America.

He focuses predominantly in the areas of M&A for domestic and multinational companies, cross-border transactions, restructuring of corporate groups, joint ventures, and other forms of business cooperation in Latin America. Artur also handles the local coordination of global antitrust matters and internal corporate investigations of fraud and violations of anticorruption and antitrust laws. Artur has been a key contributor in the São Paulo Office since its inception in 2011.

Most recently, Artur has advised GE in the divestiture of its water and industrial solution businesses, as well as Cardinal Health in the acquisition of Cordis and Fortis in Brazil. Other key clients for which Artur has advised on substantial corporate legal matters include: Banco Santander, Schibsted, TRX, Chevron, CVC Capital, and Riverside.

Experience

  • Heidrick & Struggles acquires 2GETJones Day advised Heidrick & Struggles in its acquisition of 2GET, a premier executive search firm in Brazil and one of the largest search firms in the country.
  • Chevron to buy Pasadena Refining System for $350 million from Petrobras America Inc.Jones Day is advising Chevron U.S.A. Inc., a wholly-owned subsidiary of Chevron Corporation, in its purchase of all of the equity interests of Pasadena Refining System Inc. (“PRSI”) and PRSI Trading, LLC from Petrobras America Inc. for $350 million, subject to adjustments for working capital.
  • Audax Private Equity portfolio company acquires Blue Sky IndustriesJones Day advised Audax Private Equity in connection with the acquisition by portfolio company Fastener Distribution Holdings of Blue Sky Industries, a Monterey Park, California-based distributor of c-class parts to aerospace and defense MRO and OEM customers.
  • CVC Capital Partners acquires Teva's International Women's Health assets for $703 millionJones Day advised CVC Capital Partners in its $703 million acquisition of Teva Pharmaceutical Industries Ltd's International (non-US), Women's Health assets.
  • Investcorp sells Esmalglass to Lone Star for €605 million (US$695 million)Jones Day advised Investcorp, a leading provider and manager of alternative investment products, in the €605 million (US$695 million) sale of Esmalglass, a leading producer of ceramic colors and glazes, to Lone Star.
  • Cardinal Health acquires leading patient product portfolio from Medtronic for $6.1 billionJones Day advised Cardinal Health on the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash.
  • AURELIUS sells Getronics Group for €220 million (US$251.3 million)Jones Day advised AURELIUS Equity Opportunities SE & Co. KGaA on the sale of its subsidiary Getronics to strategic investor Bottega Invest Co S.à.r.l. for €220 million (US$251.3 million) (enterprise value).
  • Timken acquires Groeneveld Group for $280 millionJones Day advised The Timken Company in its $280 million acquisition of Groeneveld Group, a leading provider of automatic lubrication solutions used in on- and off-highway applications.
  • Nissan Motor Co. in global restructuring of Takata CorporationJones Day is representing Nissan Motor Co., Ltd. in connection with the global restructuring of Takata Corporation and its subsidiaries.
  • Syndicate of lenders provides financing to Grupo Isolux Corsan for its restructuring of debtJones Day provided legal advice to a syndicate of Lenders (excluding bondholders) in a financing transaction to Grupo Isolux Corsan S.A., a listed global Spanish construction and engineering company, in the restructuring of nearly €2 billion debt owed by the worldwide-based group of companies.
  • Agence des Participations de l'Etat provides €200 million State loan to Vale Canada Limited and issues State guarantee to secure project financing of tailings storage areaJones Day represented Agence des Participations de l'Etat in connection with a €200 million (US$240 million) State loan provided to Vale Canada Limited secured by nickel finished and semi-finished product inventory held by the Vale group throughout Asia and Europe; and the issuance of a State guarantee to secure the project financing of a tailings storage area in the nickel mine operated by Vale in New Caledonia.
  • Fourth Alcuin Fund acquires minority stake in Air Charter ServiceJones Day represented The Fourth Alcuin Fund LP, a fund managed by Alcuin Capital Partners LLP, in connection with its minority stake investment in Air Charter Service, a global leader in providing aircraft charters.
  • Wendy's forms joint venture in Brazil to open restaurants in São PauloJones Day advised The Wendy's Company in establishing a franchise relationship with The Starboard Group, a large Wendy's franchise, and Infinity Services Ltda, a Brazil based restaurant investment company, and setting up a joint venture in Brazil with the intention to operate various Wendy's restaurants.
  • Cardinal Health acquires Cordis for $1.9 billionJones Day advised Cardinal Health, Inc. in its acquisition of Johnson & Johnson's Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.9 billion in cash.
  • Chevron defends against allegations of environmental damage from oil seeps off coast of BrazilJones Day is serving as lead U.S. counsel for Chevron with respect to various legal and administrative proceedings arising out of oil seeps that occurred off the coast of Brazil in November 2011 and March 2012.
  • Total finalizes acquisition by Arkema of Total's Bostik Adhesives unit for €1.74 billion (US$2.2 billion)Jones Day represented Total SA in the €1.74 billion (US$2.2 billion) acquisition by the French group Arkema, one of the world’s major players in specialty chemicals, of its Bostik affiliate, a global adhesives company.
  • Fortune 500 medical company conducts internal investigation in South America involving allegations of distributor FCPA violationsJones Day represented a Fortune 500 medical company in internal investigations in Brazil and Argentina involving potential violations of U.S. antibribery laws, including the FCPA.
  • NII Holdings amends and restructures $875 million credit facilitiesJones Day advised NII Holdings, Inc. and its subsidiaries in connection with the amendment and restructuring of its $875 million credit facilities in Mexico and Brazil with the China Development Bank.
  • TRX Imobilarios forms offshore fundsJones Day advised TRX Investimentos Imobiliários S.A. on its formation of offshore investment funds focused on the acquisition and development of single family homes, self-storage facilities, modular warehouses, and office complexes in the United States.
  • Manufacturer resolves investigation into alleged cartel activitiesJones Day represented a manufacturer facing investigations by multiple competition authorities regarding alleged cartel activity in the autoparts industry.
    • View All

    September 2019 Commentaries

    Companies Are Now Getting Ready for Brazil’s New Data Protection Law

    August 2018 Commentaries

    Brazil Enacts General Data Protection Law

    July 2018 Alerts

    Brazil's Mining Reforms Target Environmental Impact, Public Safety, Royalty Payments

    December 2017 Commentaries

    Brazilian Labor Reform: Reshaping the Employer–Employee Relationship

    March 2016 Alerts

    Brazilian Government Increases Cap on Foreign Ownership of Brazilian Airlines

    October 2015 Alerts

    Brazilian Government Proposes Increase in Capital Gains Rates

    June 2009 Alerts

    Antitrust Alert: Brazil Requires Divestiture in Coca-Cola’s Iced Tea Acquisition

    Speaking Engagements

    • May 15, 2018
      The new European regulation on data protection (GDPR) for Brazilian businesses
    • November 20, 2015
      Investing in Latin America: Recent Legal and Tax Developments
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.